we conclude ( 1 ) there is a heterogeneous response to lisinopril in patients with chronic renal disease and hypertension , ( 2 ) lisinopril monotherapy may result in effective blood pressure control without renal hemodynamic compromise , and ( 3 ) an increase in pra following converting enzyme inhibition may identify those in whom the circulating renin angiotensin system is participating in systemic hypertension and intrarenal hemodynamic changes .
C0022661
chronic renal disease
C0022646
renal